Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space
Go back to Goldman Calls Medicis (MRX) 'One of the Most Likely M&A Targets' in Specialty Pharma Space| Medicis Pharmaceutical Corp. (NASDAQ: MRX) | Delayed: 70.19 -1.69 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.88 | 52 Week High | $44.00 | |||
| Open | $72.29 | 52 Week Low | $30.30 | |||
| Day High | $73.75 | P/E | 101.72 | |||
| Day Low | $70.03 | EPS | $0.69 | |||
| Volume | 426,813 | |||||
